Greater absolute benefit with PCSK9 inhibition in diabetes patients - PACE-CME

Greater absolute benefit with PCSK inhibition in diabetes patients

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Comprehensive management of individuals with CKM syndrome
Comprehensive management of individuals with CKM syndrome
MinuteCE®
Comprehensive management of individuals with CKM syndrome
1.00 program credit
- Muthiah Vaduganathan, MD
1.00 program credit
Case-based learning and future directions
Case-based learning and future directions
MinuteCE®
Case-based learning and future directions
1.00 program credit
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
- Muthiah Vaduganathan, MD, MPH
- Jurgen Floege MD
1.00 program credit
Effects of empaglifozin on kidney outcomes after acute MI
Effects of empaglifozin on kidney outcomes after acute MI
ESC Congress 2024
Effects of empaglifozin on kidney outcomes after acute MI
- Deepak Bhatt, MD
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
ACC.24
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
- James Januzzi, MD